Human immunodeficiency virus (HIV) is a virus that attacks the white blood cells called helper T cells (CD4). These cells are part of the immune system. They fight off infections and disease. As a result, an HIV infection can leave you vulnerable to severe illnesses.
AIDS is a late stage of HIV infection. It reflects severe damage to the immune system. One or more opportunistic infections will also likely exist. Opportunistic infections are a type of infection that only occur in people with compromised immune systems.
HIV is spread through contact with HIV-infected blood or other body fluids. This includes semen, vaginal fluid, and breast milk. The infection may be the result of HIV-1 or HIV-2 virus.
AIDS is caused by the destruction of T cells. The destruction is caused by the HIV virus.
HIV destroys white blood cells vital to the immune system.
Copyright © Nucleus Medical Media, Inc.
HIV is most commonly spread through:
Rarely, HIV can be spread through:
Factors that increase your chance of getting HIV include:
HIV infection increases the chances of getting AIDS.
HIV may not cause symptoms for a number of years.
Early symptoms may appear a month or two after becoming infected. They may last a couple of weeks and be similar to the flu or mononucleosis. These include:
After these initial symptoms pass, there may be no symptoms for months to years. The following symptoms may occur over the years:
If left untreated, HIV infection progresses to AIDS. This may happen when the number of T helper cells fall below certain levels and opportunistic infections arise. People with AIDS are susceptible to many health complications. These may include:
Your doctor will ask about your symptoms and medical history. A physical exam will be done. To confirm a diagnosis of HIV infection, your doctor will run tests. These may include:
Medications can prevent, delay, or control the development of AIDS in many people infected with HIV.
Antiviral drugs are often given in combination. Categories of these drugs include:
People who have developed AIDS may be given other medications to help fight infections that are more likely to occur with a weak immune system. These may include antibiotics or antifungal medications.
In general, to reduce your chances of getting HIV infection, take these steps:
If you are a health care worker or work in a correctional facility, take these steps:
If you live in a household with an HIV-infected person, take these steps:
If you are infected with HIV, take these steps to prevent spreading HIV to others:
American Foundation for AIDS Research
Centers for Disease Control and Prevention
AIDS Committee of Toronto
Canadian AIDS Society
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. AIDS Info website. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Updated February 12, 2013. Accessed June 3, 2013.
HIV/AIDS: The basics. AIDS info website. Available at: http://aidsinfo.nih.gov/contentfiles/HIVAIDS_theBasics.pdf. Updated August 2012. Accessed June 3, 2013.
HIV infection. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated May 21, 2013. Accessed June 3, 2013.
HIV transmission risk. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/hiv/law/pdf/HIVtranmsmision.pdf. Published July 2012. Accessed August 14, 2014.
Montaner JS. Treatment as prevention: a double hat-trick. Lancet. 2011 Jul 16;378(9787):208-209.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/nchstp/od/nchstp.html. Updated March 7, 2013. Accessed June 3, 2013.
Primary HIV infection. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated February 13, 2013. Accessed June 3, 2013.
Preventing transmission of HIV. AIDS info website. Available at: http://aidsinfo.nih.gov/contentfiles/UnderstandingHIVPrevention_FS_en.pdf. Updated August 2012. Accessed June 3, 2013.
Rey D, Krebs M, Partisani M, Hess G, et al. Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients. J Acquir Immune Defic Syndr. 2006;43: 530-534.
Ross LL, Parkin N, Gerondelis P, et al. Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility. J Acquir Immune Defic Syndr. 2006;43(5):567-570.
Testing for HIV. AIDS info website. Available at: http://aidsinfo.nih.gov/contentfiles/TestingPositive_FS_en.pdf. Updated August 2012. Accessed June 3, 2013.
Workowski KA, Berman S, Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR. 2010;59(No. RR-12):1-110.
3/8/2007 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Auvert B, Taljaard D, Lagard E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298. Epub Oct 25, 2005.
Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369(9562):643-656.
Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007 Feb 24;369(9562):657-666.
2/21/2008 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Mallal S, Phillips E, Carosi G, et al. HLA-B5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358:568-579.
6/11/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Del Romero J, Castilla J, Hernando V, Rodríguez C, García S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ. 2010:c2205.
10/8/2014 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: British Association of Sexual Health and HIV (BASHH) recommendations on testing for sexually transmitted infections in men who have sex with men. Available at: http://www.bashh.org/documents/BASHH%20Recommendations%20for%20testing%20for%20STIs%20in%20MSM%20-%20FINAL.pdf. Updated 2014. Accessed October 8, 2014.
Last reviewed May 2014 by David L. Horn, MD, FACPLast Updated: 10/8/2014